TAK 599
- CAS NO.:400827-46-5
- Empirical Formula: C24H25N8O10PS4
- Molecular Weight: 744.72
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-08 21:13:59
What is TAK 599?
Description
Ceftaroline fosamil, also referred to as TAK-599, is a cephalosporin antibacterial agent that was approved in the United States in October 2010 for the IV treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP). Ceftaroline fosamil is the water-soluble, N-phosphono prodrug of ceftaroline (T-91825), a broad-spectrum, bactericidal agent with potent activity against methicillin-resistant Staphylococcus aureus (MRSA) strains, multidrug resistant S. pneumonia, and common gram-negative organisms. Ceftaroline binds to PBP2a as well as other PBPs with high affinity and, as a result, retains potent activity. Ceftaroline exhibits activity against most gram-positive pathogens, including β-lactam-susceptible and -resistant S. aureus, vancomycin-resistant S. aureus, and resistant and susceptible forms of S. pneumoniae but has weak activity against Enterococcus sp. The gram-negative antibacterial activity of ceftaroline is limited mainly to respiratory pathogens such as Moraxella catarrhalis and Haemophilus influenzae.
Originator
Takeda (Japan)
Definition
ChEBI: An acetate salt obtained by reaction of ceftaroline fosamil with one equivalent of acetic acid. A prodrug for ceftaroline, used for the treatment of adults with acute bacterial skin and skin structure infections.
brand name
Teflaro
Synthesis
Reports from Takeda describe a process preparation of ceftaroline
fosamil in 100 g scale which relies upon the assembly and union
of fragments 112 and 114. The
synthesis of fragment 112 began from commercially available
benzhydryl 7b-[(phenylacetyl)amino]-3-hydroxy-3-cephem-4-
carboxylate (106). The hydroxyl group within cephem 106 was reacted
with methanesulfonyl chloride to produce mesylate 107 in
94% yield. The condensation of mesylate 107 with 4-(pyridin-
4-yl)thiazole-2-thiol 108 under the base condition of sodium
methoxide gave compound 109 in 78% yield. Pyridinium salt 110 arose in quantitative yield upon subjection of 109 to iodomethane.
Sequential deprotections of the amino group with phosphorous
pentachloride and ester group with concentrated HCl afforded
the dihydrochloride salt 112 in good yield.
Acyl halide fragment 114 was prepared from commercially
available (Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetic
acid (113) in 60% yield by dichlorophosphorylation of the amino
group and concomitant acid chloride formation. Acid chloride 114
was then reacted with dihydrochloride salt 112 in the presence of
sodium acetate to give N-phosphono cephem 115 in 77% yield. The
crystallization of 115 in an aqueous acetic acid solution gave rise to
the stable acetic acid solvate ceftaroline fosamil acetate (IX).
Drug interactions
Potentially hazardous interactions with other drugs
Anticoagulants: effects of coumarins may be
enhanced.
Metabolism
Ceftaroline fosamil (prodrug) is converted into the active
ceftaroline in plasma by phosphatase enzymes. Hydrolysis
of the beta-lactam ring of ceftaroline occurs to form
the microbiologically inactive, open-ring metabolite,
ceftaroline M-1.
Ceftaroline is mainly eliminated by the kidneys. Renal
clearance is approximately equal, or slightly lower than
the glomerular filtration rate in the kidney, and in vitro
transporter studies indicate that active secretion does not
contribute to the renal elimination of ceftaroline.
Properties of TAK 599
storage temp. | Store at -20°C |
solubility | DMSO : 30 mg/mL (40.28 mM; Need ultrasonic and warming) |
form | Powder |
color | White to light yellow |
Safety information for TAK 599
Computed Descriptors for TAK 599
Abamectin manufacturer
Aavyan Labs
Archerchem Healthcare Pvt., Ltd. (part of Archerchem Group)
New Products
ALUMINIUM IODIDE 100 GM BUFFER CAPSULE PH 7.0 - 10 CAP BUFFER SOLUTION PH 9.5 (BORATE) EZEE BLUE GEL STAINER BORAX CARMINE (GRENACHERS ALCOHOLIC) POTASSIUM IODATE - IODIDE SOLN 0.1 N Dabigatran Acyl-O3-D-Glucuronide Trifluoroacetic Acid Salt Isofolic Acid Dabigatran 2-O-acylglucuronide metabolite Dabigatran Acyl-?-D- glucuronide Trifluroacetic Acid Erythromycin EP Impurity A Desloratidine Related Compound ARelated products of tetrahydrofuran
You may like
-
400827-46-5 Ceftaroline fosamil 98%View Details
400827-46-5 -
Ceftaroline fosamil acetate hydrate CAS 400827-46-5View Details
400827-46-5 -
Dechloro DesloratadineView Details
-
Dehydro DesloratadineView Details
-
Edoxaban Impurity 57View Details
2089454-69-1 -
Empagliflozin Bromo ImpurityView Details
-
Glycopyrronium Bromide EP Impurity IView Details
1404617-94-2 -
Ipratropium EP Impurity BView Details
58073-59-9